Logo image of UTHR

UNITED THERAPEUTICS CORP (UTHR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:UTHR - US91307C1027 - Common Stock

473.36 USD
+4.42 (+0.94%)
Last: 1/26/2026, 8:00:02 PM
473.36 USD
0 (0%)
After Hours: 1/26/2026, 8:00:02 PM
Fundamental Rating

7

Overall UTHR gets a fundamental rating of 7 out of 10. We evaluated UTHR against 525 industry peers in the Biotechnology industry. UTHR has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. UTHR has a correct valuation and a medium growth rate. These ratings could make UTHR a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year UTHR was profitable.
  • UTHR had a positive operating cash flow in the past year.
  • In the past 5 years UTHR has always been profitable.
  • UTHR had a positive operating cash flow in each of the past 5 years.
UTHR Yearly Net Income VS EBIT VS OCF VS FCFUTHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

  • UTHR's Return On Assets of 17.30% is amongst the best of the industry. UTHR outperforms 96.00% of its industry peers.
  • UTHR has a Return On Equity of 19.30%. This is amongst the best in the industry. UTHR outperforms 95.62% of its industry peers.
  • UTHR has a better Return On Invested Capital (17.33%) than 96.95% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for UTHR is below the industry average of 18.07%.
  • The 3 year average ROIC (14.96%) for UTHR is below the current ROIC(17.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 17.3%
ROE 19.3%
ROIC 17.33%
ROA(3y)14%
ROA(5y)12.47%
ROE(3y)16.72%
ROE(5y)15.47%
ROIC(3y)14.96%
ROIC(5y)13.31%
UTHR Yearly ROA, ROE, ROICUTHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

  • UTHR's Profit Margin of 40.65% is amongst the best of the industry. UTHR outperforms 97.14% of its industry peers.
  • In the last couple of years the Profit Margin of UTHR has grown nicely.
  • With an excellent Operating Margin value of 48.65%, UTHR belongs to the best of the industry, outperforming 99.62% of the companies in the same industry.
  • In the last couple of years the Operating Margin of UTHR has grown nicely.
  • UTHR has a better Gross Margin (88.59%) than 90.67% of its industry peers.
  • In the last couple of years the Gross Margin of UTHR has remained more or less at the same level.
Industry RankSector Rank
OM 48.65%
PM (TTM) 40.65%
GM 88.59%
OM growth 3Y7.2%
OM growth 5Y2.85%
PM growth 3Y13.74%
PM growth 5YN/A
GM growth 3Y-1.27%
GM growth 5Y-0.58%
UTHR Yearly Profit, Operating, Gross MarginsUTHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

9

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), UTHR is creating value.
  • UTHR has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for UTHR has been increased compared to 5 years ago.
  • UTHR has a better debt/assets ratio than last year.
UTHR Yearly Shares OutstandingUTHR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
UTHR Yearly Total Debt VS Total AssetsUTHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 19.07 indicates that UTHR is not in any danger for bankruptcy at the moment.
  • UTHR has a Altman-Z score of 19.07. This is amongst the best in the industry. UTHR outperforms 88.19% of its industry peers.
  • UTHR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 19.07
ROIC/WACC1.96
WACC8.82%
UTHR Yearly LT Debt VS Equity VS FCFUTHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

  • UTHR has a Current Ratio of 6.40. This indicates that UTHR is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of UTHR (6.40) is better than 65.33% of its industry peers.
  • A Quick Ratio of 6.07 indicates that UTHR has no problem at all paying its short term obligations.
  • UTHR's Quick ratio of 6.07 is fine compared to the rest of the industry. UTHR outperforms 64.57% of its industry peers.
Industry RankSector Rank
Current Ratio 6.4
Quick Ratio 6.07
UTHR Yearly Current Assets VS Current LiabilitesUTHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

6

3. Growth

3.1 Past

  • UTHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.90%, which is quite good.
  • Measured over the past years, UTHR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.88% on average per year.
  • UTHR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.50%.
  • Measured over the past years, UTHR shows a quite strong growth in Revenue. The Revenue has been growing by 14.71% on average per year.
EPS 1Y (TTM)15.9%
EPS 3Y34.86%
EPS 5Y16.88%
EPS Q2Q%12.05%
Revenue 1Y (TTM)13.5%
Revenue growth 3Y19.52%
Revenue growth 5Y14.71%
Sales Q2Q%6.76%

3.2 Future

  • UTHR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.57% yearly.
  • UTHR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.21% yearly.
EPS Next Y12.48%
EPS Next 2Y9.45%
EPS Next 3Y8.97%
EPS Next 5Y11.57%
Revenue Next Year11.46%
Revenue Next 2Y8.55%
Revenue Next 3Y9.27%
Revenue Next 5Y11.21%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
UTHR Yearly Revenue VS EstimatesUTHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
UTHR Yearly EPS VS EstimatesUTHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30 40 50

6

4. Valuation

4.1 Price/Earnings Ratio

  • UTHR is valuated rather expensively with a Price/Earnings ratio of 17.94.
  • Based on the Price/Earnings ratio, UTHR is valued cheaper than 95.24% of the companies in the same industry.
  • UTHR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.25.
  • Based on the Price/Forward Earnings ratio of 16.06, the valuation of UTHR can be described as correct.
  • 95.43% of the companies in the same industry are more expensive than UTHR, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.98, UTHR is valued a bit cheaper.
Industry RankSector Rank
PE 17.94
Fwd PE 16.06
UTHR Price Earnings VS Forward Price EarningsUTHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • UTHR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. UTHR is cheaper than 97.33% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, UTHR is valued cheaper than 95.81% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.26
EV/EBITDA 9.97
UTHR Per share dataUTHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of UTHR may justify a higher PE ratio.
PEG (NY)1.44
PEG (5Y)1.06
EPS Next 2Y9.45%
EPS Next 3Y8.97%

0

5. Dividend

5.1 Amount

  • UTHR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

UNITED THERAPEUTICS CORP / UTHR FAQ

What is the fundamental rating for UTHR stock?

ChartMill assigns a fundamental rating of 7 / 10 to UTHR.


What is the valuation status of UNITED THERAPEUTICS CORP (UTHR) stock?

ChartMill assigns a valuation rating of 6 / 10 to UNITED THERAPEUTICS CORP (UTHR). This can be considered as Fairly Valued.


Can you provide the profitability details for UNITED THERAPEUTICS CORP?

UNITED THERAPEUTICS CORP (UTHR) has a profitability rating of 9 / 10.


What are the PE and PB ratios of UNITED THERAPEUTICS CORP (UTHR) stock?

The Price/Earnings (PE) ratio for UNITED THERAPEUTICS CORP (UTHR) is 17.94 and the Price/Book (PB) ratio is 3.09.


What is the expected EPS growth for UNITED THERAPEUTICS CORP (UTHR) stock?

The Earnings per Share (EPS) of UNITED THERAPEUTICS CORP (UTHR) is expected to grow by 12.48% in the next year.